Biosafety standards for working with Crimean-Congo hemorrhagic fever virus.
J Gen Virol
; 97(11): 2799-2808, 2016 Nov.
Article
en En
| MEDLINE
| ID: mdl-27667586
ABSTRACT
In countries from which Crimean-Congo haemorrhagic fever (CCHF) is absent, the causative virus, CCHF virus (CCHFV), is classified as a hazard group 4 agent and handled in containment level (CL)-4. In contrast, most endemic countries out of necessity have had to perform diagnostic tests under biosafety level (BSL)-2 or -3 conditions. In particular, Turkey and several of the Balkan countries have safely processed more than 100 000 samples over many years in BSL-2 laboratories. It is therefore advocated that biosafety requirements for CCHF diagnostic procedures should be revised, to allow the tests required to be performed under enhanced BSL-2 conditions with appropriate biosafety laboratory equipment and personal protective equipment used according to standardized protocols in the countries affected. Downgrading of CCHFV research work from CL-4, BSL-4 to CL-3, BSL-3 should also be considered.
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Exposición Profesional
/
Virus de la Fiebre Hemorrágica de Crimea-Congo
/
Contención de Riesgos Biológicos
/
Fiebre Hemorrágica de Crimea
Tipo de estudio:
Guideline
Límite:
Animals
/
Humans
Idioma:
En
Revista:
J Gen Virol
Año:
2016
Tipo del documento:
Article
País de afiliación:
Reino Unido